[Allogeneic hematopoietic stem cell transplantation for solid tumors].
Kanda
Yoshinobu
Y
D000818:Animals; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D003131:Combined Modality Therapy; D006086:Graft vs Host Disease; D020350:Graft vs Tumor Effect; D006680:HLA Antigens; D018380:Hematopoietic Stem Cell Transplantation / Q000379:methods; D006648:Histocompatibility; D006801:Humans; D007167:Immunotherapy / Q000379:methods; D007963:Leukocytes, Mononuclear / Q000637:transplantation; D015778:Minor Histocompatibility Antigens / Q000276:immunology; D009369:Neoplasms / Q000276:immunology / Q000628:therapy*; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology; D019172:Transplantation Conditioning / Q000379:methods; D014184:Transplantation, Homologous
D006680:HLA Antigens; D015778:Minor Histocompatibility Antigens